These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 33880584

  • 1. Structured triglyceride attenuates lung injury and inflammation in lipopolysaccharide‑induced acute lung injury by enhancing GPR120 expression.
    Sun H, Pang Y, Zhao D, Li W.
    Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880584
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA‑17 contributes to the suppression of the inflammatory response in lipopolysaccharide‑induced acute lung injury in mice via targeting the toll‑like receptor 4/nuclear factor‑κB pathway.
    Fu S.
    Int J Mol Med; 2020 Jul; 46(1):131-140. PubMed ID: 32626914
    [Abstract] [Full Text] [Related]

  • 3. miR‑26a‑5p alleviates lipopolysaccharide‑induced acute lung injury by targeting the connective tissue growth factor.
    Li H, Yang T, Fei Z.
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33179083
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MicroRNA‑129 plays a protective role in sepsis‑induced acute lung injury through the suppression of pulmonary inflammation via the modulation of the TAK1/NF‑κB pathway.
    Yao W, Xu L, Jia X, Li S, Wei L.
    Int J Mol Med; 2021 Jul; 48(1):. PubMed ID: 34080641
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Tumor necrosis factor α‑induced protein 8‑like 2 contributes to penehyclidine hydrochloride pretreatment against lipopolysaccharide‑induced acute lung injury in a mouse model.
    Yuan M, Jing G, Kong Q, Ming T, Song X, Wu X.
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34468006
    [Abstract] [Full Text] [Related]

  • 8. Expression level of 12-amino acid triggering receptor on myeloid cells-like transcript 1 derived peptide alleviates lipopolysaccharide-induced acute lung injury in mice.
    Shi R, Zhang J, Peng Z, Yuan S, Gao S, Chen L, Yuan Y.
    Int J Mol Med; 2018 Apr; 41(4):2159-2168. PubMed ID: 29393375
    [Abstract] [Full Text] [Related]

  • 9. JNK‑IN‑8 treatment alleviates lipopolysaccharide‑induced acute lung injury via suppression of inflammation and oxidative stress regulated by JNK/NF‑κB signaling.
    Du J, Wang G, Luo H, Liu N, Xie J.
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33355369
    [Abstract] [Full Text] [Related]

  • 10. Puerarin prevents LPS-induced acute lung injury via inhibiting inflammatory response.
    Wang X, Yan J, Xu X, Duan C, Xie Z, Su Z, Ma H, Ma H, Wei X, Du X.
    Microb Pathog; 2018 May; 118():170-176. PubMed ID: 29571724
    [Abstract] [Full Text] [Related]

  • 11. All‑trans retinoic acid promotes macrophage phagocytosis and decreases inflammation via inhibiting CD14/TLR4 in acute lung injury.
    Li S, Lei Y, Lei J, Li H.
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34676874
    [Abstract] [Full Text] [Related]

  • 12. Necrostatin-1 attenuates lipopolysaccharide-induced acute lung injury in mice.
    Guan E, Wang Y, Wang C, Zhang R, Zhao Y, Hong J.
    Exp Lung Res; 2017 Dec; 43(9-10):378-387. PubMed ID: 29199874
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic effect of methyl salicylate 2-O-β-d-lactoside on LPS-induced acute lung injury by inhibiting TAK1/NF-kappaB phosphorylation and NLRP3 expression.
    Yang S, Yu Z, Yuan T, Wang L, Wang X, Yang H, Sun L, Wang Y, Du G.
    Int Immunopharmacol; 2016 Nov; 40():219-228. PubMed ID: 27620503
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA‑93 contributes to the suppression of lung inflammatory responses in LPS‑induced acute lung injury in mice via the TLR4/MyD88/NF‑κB signaling pathway.
    Gao H, Xiao D, Gao L, Li X.
    Int J Mol Med; 2020 Aug; 46(2):561-570. PubMed ID: 32468034
    [Abstract] [Full Text] [Related]

  • 15. Anti-inflammatory effects of triptolide by inhibiting the NF-κB signalling pathway in LPS-induced acute lung injury in a murine model.
    Wang X, Zhang L, Duan W, Liu B, Gong P, Ding Y, Wu X.
    Mol Med Rep; 2014 Jul; 10(1):447-52. PubMed ID: 24789089
    [Abstract] [Full Text] [Related]

  • 16. Dihydroartemisinin attenuates lipopolysaccharide‑induced acute lung injury in mice by suppressing NF‑κB signaling in an Nrf2‑dependent manner.
    Huang XT, Liu W, Zhou Y, Hao CX, Zhou Y, Zhang CY, Sun CC, Luo ZQ, Tang SY.
    Int J Mol Med; 2019 Dec; 44(6):2213-2222. PubMed ID: 31661121
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-92a antagonism attenuates lipopolysaccharide (LPS)-induced pulmonary inflammation and injury in mice through suppressing the PTEN/AKT/NF-κB signaling pathway.
    Fu L, Zhu P, Qi S, Li C, Zhao K.
    Biomed Pharmacother; 2018 Nov; 107():703-711. PubMed ID: 30138892
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-17 antagonist attenuates lung inflammation through inhibition of the ERK1/2 and NF-κB pathway in LPS-induced acute lung injury.
    Li TJ, Zhao LL, Qiu J, Zhang HY, Bai GX, Chen L.
    Mol Med Rep; 2017 Aug; 16(2):2225-2232. PubMed ID: 28656298
    [Abstract] [Full Text] [Related]

  • 19. AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway.
    Wang X, Yang B, Li Y, Luo J, Wang Y.
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34590152
    [Abstract] [Full Text] [Related]

  • 20. Knockdown of versican V1 induces a severe inflammatory response in LPS-induced acute lung injury via the TLR2-NF-κB signaling pathway in C57BL/6J mice.
    Xu L, Xue T, Zhang J, Qu J.
    Mol Med Rep; 2016 Jun; 13(6):5005-12. PubMed ID: 27109786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.